Who Paid My Doc Search
Menu
Product Program year 2021 Source: CMS Open Payments

Comirnaty

Biological Vaccines

NDC 0069-1000-03

Open in the dashboard

General payments

$232,494

22 payments

Research payments

$242,734,244

8,831 payments

Through program year 2021, $232,494 in general payments and $242,734,244 in research payments were reported against Comirnaty (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $232,494 22
2021 Research $242,734,244 8,831

Breakdown

Who paid General payments · program year 2021
  1. Pfizer Inc. $220,494 19 payments
  2. Pfizer International LLC $12,000 3 payments
Top recipients General payments · program year 2021
  1. U Of U Hospitals & Clinics Teaching hospital · UT $70,000 30% · 1 payment
  2. Hackensack University Medical Center Teaching hospital · NJ $50,000 22% · 2 payments
  3. The University Of Texas Medical Br. Teaching hospital · TX $50,000 22% · 1 payment
  4. Lawrence Stanberry Pediatric Infectious Diseases · Galveston, TX $13,475 6% · 4 payments
  5. Robert Belshe Infectious Disease · Saint Louis, MO $12,950 6% · 3 payments

The top 5 of 12 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Infectious Disease Internal Medicine $25,229 42% · 3 practitioners
  2. Pediatric Infectious Diseases Pediatrics $21,275 35% · 2 practitioners
  3. Maternal & Fetal Medicine Obstetrics & Gynecology $4,900 8% · 1 practitioner
  4. Diagnostic Radiology Radiology $4,440 7% · 1 practitioner
  5. Public Health & General Preventive Medicine Preventive Medicine $4,200 7% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. Utah $70,000 30% · 1 recipient
  2. New Jersey $50,000 22% · 1 recipient
  3. Texas $50,000 22% · 1 recipient
  4. New York $18,439 8% · 2 recipients
  5. Missouri $12,950 6% · 1 recipient

The top 5 of 10 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

Records

22 general · 8,831 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record